The ingredient, dose, concentration, infusion rate, tolerance, number of substances, and clinical setting affect duration
Most current discussion comes from small observational studies, conference reports, case experience, and biologic plausibility
CJC-1295 No DAC + Ipamorelin 10mg Research Blend This blend contains two distinct research peptides CJC-1295 No DAC and Ipamorelin each supplied at 5mg for a combined 10mg per vial
Although the FLOW trial and the secondary analysis of the SELECT trial have demonstrated important kidney benefits of semaglutide, the kidney-protective effects of other GLP-1 receptor agonists are less well known, as there have not been prospective trials with kidney outcomes, and it is unclear whether the benefits of these medications are a class effect or are medication specific